The managed hypertensive: The costs of blood pressure control in a nigerian town

Pan African Medical Journal

Volumn 12, Issue 1, 2012, Pages

  Ilesanmi, Olayinka Stephen ^a   Ige, Olusimbo Kehinde ^a   Adebiyi, Akindele Olupelumi ^a,b  

^a UNIVERSITY OF IBADAN   (Nigeria)

^b UNIVERSITY OF IBADAN   (Nigeria)

Author keywords

Burden; Cost; Drugs; Financial; Hypertensive; Management; Nigeria; Patients; Resources; Therapy; Time

Indexed keywords

AMILORIDE PLUS HYDROCHLOROTHIAZIDE; ATENOLOL; DIURETIC AGENT; LISINOPRIL; METHYLDOPA; NIFEDIPINE;

ADULT; ARTICLE; BLOOD PRESSURE REGULATION; COMORBIDITY; COST EFFECTIVENESS ANALYSIS; FEMALE; HEALTH CARE COST; HUMAN; HYPERTENSION; INCOME; MAJOR CLINICAL STUDY; MALE; NIGERIA; RURAL AREA;

EID: 84871484396     PISSN: 19378688     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Gaziano TA. Economic burden and the cost-effectiveness of treatment of cardiovascular diseases in Africa. Heart. 2008 Feb;94(2):140-4. This article on PubMed
2. Amira CO, Okubadejo NU. Antihypertensive pharmacotherapy in a developing economy: pattern, acquisition costs and conformity to international guidelines in a tertiary-care setting. J Hum Hypertens. 2006 Nov;20(11):894-7. This article on PubMed
3. Obikeze OO, Ige OK, Osungbade KO, Olumide EA, Asuzu MC. An overview of the National Health Insurance Scheme in Nigeria. Dokita. 2010;1:15-21
4. Kadiri S. Tackling cardiovascular disease in Africa. BMJ. 2005;331:711-2. This article on PubMed
5. Omoniyi A Olawale, Owoaje ET. Incidence and pattern of injuries among residents of a rural area in South-Western Nigeria: a community-based study. BMC Public Health. 2007;7:246. This article on PubMed
6. Chobanian AV, Bakris GL, Black HR, Cushman WC, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003 May 21;289(19):2560-72. This article on PubMed
7. ISPOR. Accomplishments. ISPOR Medication Compliance And Persistence Special Interest Group (MCP). Available at: http://www.ispor.org/sigs/mcp_accomplishments.asp. Accessed 21 June 2011
8. Kucerová M, Straková M, Polívková Z. The Prader-Willi syndrome with a 15/3 translocation. J Med Genet. 1979 Jun;16(3):234-5. This article on PubMed
9. Twagirumukiza M, Bortel LMV. Management of hypertension at the community level in Sub-Saharan Africa (SSA): towards a rational use of available resources. Journal of Human Hypertension. 2011;25:47-56. This article on PubMed
10. Yusuff KB, Balogun OB. Pattern of drug utilization among hypertensives in a Nigerian teaching hospital. Pharmacoepidemiol Drug Saf. 2005 Jan;14(1):69-74. This article on PubMed
11. Edwards PR, Lunt DW, Fehrsen GS, Lombard CJ, Steyn K. Improving cost-effectiveness of hypertension management at a community health centre. S Afr Med J. 1998;88(5):549-54. This article on PubMed
12. Pillay T, Smith AJ, Hill SR. A comparison of two methods for measuring anti-hypertensive drug use: concordance of use with South African standard treatment guidelines. Bull World Health Organ. 2009;87(6):466-71. This article on PubMed
13. Ambrosioni E. Pharmacoeconomics of hypertension management: the place of combination therapy. Pharmacoeconomics. 2001;19:337-47. This article on PubMed
14. Degli-Esposti L, Di Martino M, Saragoni S, Sgreccia A, Capone A, Buda S, Degli-Esposti E. Pharmacoeconomics of antihypertensive drug treatment: an analysis of how long patients remain on various antihypertensive therapies. J Clin Hypertens(Greenwich). 2004;6(2):76-84. This article on PubMed
15. Dias da Costa JS, Fuchs SC, Olinto MT, Gigante DP, Menezes AM, et al MSe. Cost effectiveness of hypertension treatment: a population based study. Sao Paulo Med J. 2002;120:100-4. This article on PubMed
16. Appel L. The verdict from ALLHAT - thiazide diuretics are the preferred initial therapy for hypertension. JAMA. 2002;288:3039-42. This article on PubMed
17. Seedat YK, Croasdale MA, Milne FJ, et al. South African hypertension guideline 2006. S Afr Med J. 2006 Apr;96(4 Pt 2):337-62. This article on PubMed
18. Ohene Buabeng K, Matowe L, Plange-Rhule J. Unaffordable drug prices: the major cause of non-compliance with hypertension medication in Ghana. J Pharm Pharm Sci. 2004;7(3):350-2. This article on PubMed
19. Konin C, Adoh M, Coulibaly I, Kramoh E, Safou M, N'Guetta R, N'Djessan JJ, Koffi J. Black Africans' compliance to antihypertensive treatment. Arch Mal Coeur Vaiss. 2007;100(8):630-4. This article on PubMed
20. Adigun AQ, Ishola DA, Akintomide AO, Ajayi AAL. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, rationality and pharmaco-economics of old and newer antihypertensive drugs. J Hum Hypertens. 2003;17:277-85. This article on PubMed
21. Sharma A, Wittchen H, Kirch W, Pittrow D, Ritz E, Goke B, Lehnert H, Tschope D, Krause P, Hofler M, et al. High prevalence and poor control of hypertension in primary care: cross-sectional study. J Hypertens. 2004;22(3):479-86. This article on PubMed
22. Degli-Esposti E, Sturani A, Degli-Esposti L, Macini P, Falasca P, Valpiani G, Buda S. Pharmacoutilization of antihypertensive drugs: a model of analysis. Int J Clin Pharmacol Ther. 2001;39(6):251-8. This article on PubMed
23. Ige OK, Nwachukwu CC. Areas of dissatisfaction with primary health care services in government owned health facilities in a semi urban community in Nigeria. Journal of Rural and Tropical Public Health. 2010; 9:19-23